Skip to main content

Blogs

Ron Manderscheid, Executive Director, NACBHDD and NARMH
July 18, 2019
It concerns me greatly. I must write again in support of the foundational concept that all Americans should have access to good health insurance. As has happened so many times over the past decade,…
Rebecca J. Flood
July 10, 2019
Enrollment in therapy continues to be a major roadblock for addiction care. Interventions and self-enrollment are still viable and critical ways of entering treatment, but statistically speaking,…
Ron Manderscheid, Executive Director, NACBHDD and NARMH
July 02, 2019
This Independence Day will mark the 243rd anniversary of our national Declaration of Independence. This monumental document was signed by 56 very courageous souls in Philadelphia on a torturous, hot…
Andrew Penn, RN, MS, NP, CNS, APRN-BC
June 25, 2019
BLOG: I recently completed 24 hours of online training to qualify for a buprenorphine “X” waiver and can now, in addition to the schedule II to V drugs that I was already permitted to prescribe as a…
Ron Manderscheid, Executive Director, NACBHDD and NARMH
June 18, 2019
Public confusion between cannabidiol (CBD) and tetrahydrocannabinol (THC) is stymying essential medical progress in the treatment of a range of illnesses.
Kevin Turner
June 12, 2019
Instead of settling for an off-the-shelf solution, invest in a space that strikes a balance between feel, the needs of the patients and appropriate safety features.
Michael Myers, MD
June 10, 2019
BLOG: This is a dispatch from Down Under. I’ve been here lecturing for the past couple of weeks on physician health and suicide prevention. On May 31, I was a panelist on the 2019 launch of the…
Rebecca Flood
June 04, 2019
More research is needed on the effectiveness of medication approaches for addiction, but the facts about the opioid crisis make a clear case for medication-supported strategies.
Ron Manderscheid, Executive Director, NACBHDD and NARMH
May 28, 2019
Recognition and treatment are critical for depression or anxiety and opioid dependence or addiction, but it's time to go further up the causal chain if we are to reduce suicide and opioid overdose…
Andrew Penn, RN, MS, NP, CNS, APRN-BC
May 23, 2019
BLOG: Esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.
Back to Top